List of insiders holdings for Apexigen Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Brookline Capital Holdings LLC Buchanan William B. Jr. 10% Owner | 2021-02-12 17:15:17 | 1,627,000 0 | 1,627,000 | Form 13D |
GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 2021-03-10 16:15:57 | 158,687 0 | 158,687 | Form 13G |
Hsu Frank J. Chief Medical Officer | 2023-08-25 19:10:45 | 0 0 | 0 | Form 4 |
Zabrowksi Dan Director | 2023-08-25 19:42:15 | 0 0 | 0 | Form 4 |
Wertheimer Samuel P Director | 2023-08-25 19:39:47 | 0 0 | 0 | Form 4 |
Smith Scott Andrew Director | 2023-08-25 19:37:02 | 0 0 | 0 | Form 4 |
RINGOLD GORDON Director | 2023-08-25 19:34:30 | 0 0 | 0 | Form 4 |
Chhabra Meenu Director | 2023-08-25 19:31:08 | 0 0 | 0 | Form 4 |
Dupont Jakob Director | 2023-08-25 19:29:10 | 0 0 | 0 | Form 4 |
CROSS HERB Director | 2023-08-25 19:24:18 | 0 0 | 0 | Form 4 |
Wong Amy SVP, Finance and Operations | 2023-08-25 19:20:21 | 0 0 | 0 | Form 4 |
Sarena Francis Willard President and COO | 2023-08-25 19:17:10 | 0 0 | 0 | Form 4 |
PEERSCHKE ELGAR Director | 2021-01-28 21:00:23 | 0 0 | 0 | Form 3 |
Duke William E. Chief Financial Officer | 2023-08-25 18:42:49 | 0 0 | 0 | Form 4 |
Yang Xiaodong Chief Executive Officer | 2023-08-25 18:37:56 | 0 0 | 0 | Form 4 |
Serafini Tito Director | 2021-01-28 21:02:34 | 0 0 | 0 | Form 3 |
Katzmann Scott A President | 2021-01-28 21:01:40 | 0 0 | 0 | Form 3 |
Sturgeon Patrick A Chief Financial Officer | 2021-01-28 21:01:12 | 0 0 | 0 | Form 3 |
Hauslein James N Director | 2021-01-28 21:00:46 | 0 0 | 0 | Form 3 |